Benicar HCT 25 mg/1 (Olmesartan Medoxomil-Hydrochlorothiazide TABLET, FILM COATED) 25 mg/1

Benicar HCT 25 mg/1 combines olmesartan medoxomil and hydrochlorothiazide for blood pressure management. This oral tablet helps regulate hypertension with a dual-action formula.

Strength

25 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0865-30)

Manufacturer / TM Owner

Cosette Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Benicar HCT 25 mg/1 is primarily used to treat high blood pressure, or hypertension. The combination of olmesartan medoxomil, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication is often prescribed for individuals who need dual-action therapy to manage their blood pressure effectively.

Side Effects

Common effects of Benicar HCT 25 mg/1 may include dizziness, fatigue, and mild nausea. Some users might experience dehydration or electrolyte imbalances due to the diuretic component. It's important to stay hydrated and monitor for any unusual symptoms while taking this medication.

Precautions & Warnings

Benicar HCT 25 mg/1 should be handled with care, especially for individuals with kidney issues or allergies to its components. It's crucial to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Regular monitoring of blood pressure and kidney function is recommended.

Avoid Interactions

Benicar HCT 25 mg/1 may interact with other medications, including certain pain relievers, other blood pressure drugs, and supplements. Alcohol and some over-the-counter medications can also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Benicar HCT 25 mg/1 is used to manage high blood pressure by combining olmesartan medoxomil and hydrochlorothiazide for dual-action therapy.

Store Benicar HCT 25 mg/1 at room temperature, away from moisture and heat, and keep it out of reach of children.

Common side effects may include dizziness, fatigue, and mild nausea. Stay hydrated and consult a healthcare provider if symptoms persist.

Benicar HCT 25 mg/1 may interact with other medications, so it's important to consult a healthcare provider before combining it with other drugs.

Long-term use of Benicar HCT 25 mg/1 should be monitored by a healthcare provider to ensure its continued safety and efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.